Quest Diagnostics Inc (DGX) has declared a quarterly dividend of $0.80 per share, payable to shareholders of record. The ex-dividend date is set for January 12, 2026, meaning investors must own shares before this date to qualify for the dividend. The payment will be made on January 27, 2026.
This dividend yields 1.69%, reflecting the annual dividend income relative to the stock price. As of November 20, 2025, Quest Diagnostics has a market capitalization of $20.9 billion and a P/E ratio of 21.60, with an EPS of 8.52.
The company, headquartered in Secaucus, New Jersey, employs approximately 45,000 full-time staff and provides diagnostic testing and information services. It operates through a nationwide network of laboratories and patient service centers, focusing on enhancing health outcomes through diagnostic insights.
The announcement highlights Quest Diagnostics' commitment to returning capital to shareholders through regular dividend payments. Investors may consider reviewing the company's dividend history and overall financial health when assessing the sustainability of these payments. Upcoming earnings are scheduled for April 20, 2026, with an EPS estimate of $2.38 and revenue expected to reach $2.8 billion.